{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:20:38Z","timestamp":1793013638307,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treatment of head and neck squamous cell carcinoma (HNSCC) remains challenging and the survival rates of affected patients remain poor. A three-dimensional organotypic co-culture (3D-OTC) model where patient derived tumor tissue is cultured on human-derived fibroblasts (dermal equivalent, DE) was evaluated regarding its comparability to primary tumor tissue and its applicability in drug resistance testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      3D-OTC models were cultured from\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910 HNSCC patients for up to 21 days. The growth pattern at the DE was compared to tumor budding of corresponding resection specimens. Furthermore, we immunohistochemically determined the immune cell infiltrate of primary tumor tissue and corresponding 3D-OTC models. Spatially resolved gene expression analysis (\u201cXenium in situ\u201d) was performed for separate regions of interest within the 3D-OTC specimens and within primary tumor tissue. Up-regulated and down-regulated genes of the 3D-OTC samples were included in gene set enrichment analysis and up-regulated genes between invasive (invading the DE) and non-invasive tumor cells within the 3D-OTC samples were included in drug resistance testing using publicly available databases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The growth pattern observed at the DE was associated with tumor budding in primary tumor tissue. The density of CD3-\/CD20-\/CD56-positive cells was lower in 3D-OTC samples compared to primary tumor tissue. No such changes were observed for CD68-positive cells and no significant changes in the density of the immune cell infiltrate were detected during the cultivation period. The centroids and dispersion of the gene expression of the 3D-OTC samples did not differ from the corresponding primary tumor tissue. The regions of interest within the 3D-OTC samples showed distinct functional states in gene set enrichment analysis. The comparison of genes up-regulated in invasive tumor parts of the 3D-OTC samples could explain resistance of tumor subclones to certain chemotherapeutics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The 3D-OTC model morphologically and transcriptomically resembles primary tumor tissue and its biology while preserving the tumor microenvironment. Furthermore, the 3D-OTC model allows the standardized evaluation of tumor tissue by the definition of transcriptomically separate regions of interest and thus, could help to evaluate the impact of personalized therapeutic interventions on the tumor and its microenvironment in vitro.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-04883-z","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:16:16Z","timestamp":1777101376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Personalizing the treatment of head and neck cancer in vitro: The 3D-OTC model"],"prefix":"10.1186","volume":"24","author":[{"given":"Fabian","family":"St\u00f6gbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Bashiri","family":"Dezfouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Engelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Budczies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iordanis","family":"Ourailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Boxberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Pigorsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Schmidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Strittmatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Mogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wollenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"3","key":"4883_CR1","doi-asserted-by":"publisher","first-page":"109282","DOI":"10.1016\/j.isci.2024.109282","volume":"27","author":"T Zhou","year":"2024","unstructured":"Zhou T, Huang W, Wang X, Zhang J, Zhou E, Tu Y, et al. Global burden of head and neck cancers from 1990 to 2019. iScience. 2024;27(3):109282.","journal-title":"iScience"},{"key":"4883_CR2","doi-asserted-by":"publisher","first-page":"106330","DOI":"10.1016\/j.oraloncology.2023.106330","volume":"138","author":"AS Parikh","year":"2023","unstructured":"Parikh AS, Yu VX, Flashner S, Okolo OB, Lu C, Henick BS, et al. Patient-derived three-dimensional culture techniques model tumor heterogeneity in head and neck cancer. Oral Oncol. 2023;138:106330.","journal-title":"Oral Oncol"},{"key":"4883_CR3","doi-asserted-by":"publisher","unstructured":"Amaral MN, Fa\u00edsca P, Ferreira HA, Gaspar MM, Reis CP. Current Insights and Progress in the Clinical Management of Head and Neck Cancer. Cancers (Basel) [Internet]. 2022;14(24). Available from: https:\/\/doi.org\/10.3390\/cancers14246079","DOI":"10.3390\/cancers14246079"},{"key":"4883_CR4","doi-asserted-by":"publisher","unstructured":"Demers I, Donkers J, Kremer B, Speel EJ. Ex Vivo Culture Models to Indicate Therapy Response in Head and Neck Squamous Cell Carcinoma. Cells [Internet]. 2020;9(11). Available from: https:\/\/doi.org\/10.3390\/cells9112527","DOI":"10.3390\/cells9112527"},{"key":"4883_CR5","doi-asserted-by":"publisher","first-page":"960340","DOI":"10.3389\/fonc.2022.960340","volume":"12","author":"CR Moya-Garcia","year":"2022","unstructured":"Moya-Garcia CR, Okuyama H, Sadeghi N, Li J, Tabrizian M, Li-Jessen NYK. models for head and neck cancer: Current status and future perspective. Front Oncol. 2022;12:960340.","journal-title":"Front Oncol"},{"key":"4883_CR6","doi-asserted-by":"publisher","first-page":"971726","DOI":"10.3389\/fmed.2022.971726","volume":"9","author":"B Seliger","year":"2022","unstructured":"Seliger B, Al-Samadi A, Yang B, Salo T, Wickenhauser C. models as tools for screening treatment options of head and neck cancer. Front Med (Lausanne). 2022;9:971726.","journal-title":"Front Med (Lausanne)"},{"key":"4883_CR7","doi-asserted-by":"publisher","unstructured":"Engelmann L, Thierauf J, Koerich Laureano N, Stark HJ, Prigge ES, Horn D et al. Organotypic Co-Cultures as a Novel 3D Model for Head and Neck Squamous Cell Carcinoma. Cancers (Basel) [Internet]. 2020;12(8). Available from: https:\/\/doi.org\/10.3390\/cancers12082330","DOI":"10.3390\/cancers12082330"},{"key":"4883_CR8","doi-asserted-by":"publisher","first-page":"666515","DOI":"10.3389\/fcell.2021.666515","volume":"9","author":"A Affolter","year":"2021","unstructured":"Affolter A, Lammert A, Kern J, Scherl C, Rotter N. Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer. Front Cell Dev Biol. 2021;9:666515.","journal-title":"Front Cell Dev Biol"},{"key":"4883_CR9","first-page":"e52614","volume":"101","author":"S Pinto","year":"2015","unstructured":"Pinto S, Stark HJ, Martin I, Boukamp P, Kyewski B. 3D Organotypic Co-culture Model Supporting Medullary Thymic Epithelial Cell Proliferation, Differentiation and Promiscuous Gene Expression. J Vis Exp. 2015;101:e52614.","journal-title":"J Vis Exp"},{"issue":"9","key":"4883_CR10","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1093\/jamia\/ocab085","volume":"28","author":"PJ Sch\u00fcffler","year":"2021","unstructured":"Sch\u00fcffler PJ, Geneslaw L, Yarlagadda DVK, Hanna MG, Samboy J, Stamelos E, et al. Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center. J Am Med Inf Assoc. 2021;28(9):1874\u201384.","journal-title":"J Am Med Inf Assoc"},{"issue":"12","key":"4883_CR11","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/s41416-023-02240-y","volume":"128","author":"F St\u00f6gbauer","year":"2023","unstructured":"St\u00f6gbauer F, Beck S, Ourailidis I, Hess J, Poremba C, Lauterbach M, et al. Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer. Br J Cancer. 2023;128(12):2295\u2013306.","journal-title":"Br J Cancer"},{"issue":"1","key":"4883_CR12","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878.","journal-title":"Sci Rep"},{"issue":"1","key":"4883_CR13","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1038\/s41467-023-43458-x","volume":"14","author":"A Janesick","year":"2023","unstructured":"Janesick A, Shelansky R, Gottscho AD, Wagner F, Williams SR, Rouault M, et al. High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis. Nat Commun. 2023;14(1):8353.","journal-title":"Nat Commun"},{"issue":"6","key":"4883_CR14","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882\u20133.","journal-title":"Bioinformatics"},{"issue":"12","key":"4883_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"12","key":"4883_CR16","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","volume":"35","author":"A Zhu","year":"2019","unstructured":"Zhu A, Ibrahim JG, Love MI. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics. 2019;35(12):2084\u201392.","journal-title":"Bioinformatics"},{"issue":"43","key":"4883_CR17","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"4883_CR18","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsd\u00f3ttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739\u201340.","journal-title":"Bioinformatics"},{"issue":"6","key":"4883_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"46","key":"4883_CR20","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1038\/s41388-021-02055-2","volume":"40","author":"D Huang","year":"2021","unstructured":"Huang D, Savage SR, Calinawan AP, Lin C, Zhang B, Wang P, et al. A highly annotated database of genes associated with platinum resistance in cancer. Oncogene. 2021;40(46):6395\u2013405.","journal-title":"Oncogene"},{"issue":"1","key":"4883_CR21","doi-asserted-by":"publisher","first-page":"25327","DOI":"10.1038\/s41598-024-75861-9","volume":"14","author":"A Palollathil","year":"2024","unstructured":"Palollathil A, Nandakumar R, Ahmed M, Velikkakath AKG, Nisar M, Nisar M, et al. HNCDrugResDb: a platform for deciphering drug resistance in head and neck cancers. Sci Rep. 2024;14(1):25327.","journal-title":"Sci Rep"},{"issue":"D1","key":"4883_CR22","first-page":"D498","volume":"48","author":"B Jassal","year":"2020","unstructured":"Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2020;48(D1):D498\u2013503.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4883_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/17460441.2024.2439456","volume":"20","author":"AS Becker","year":"2025","unstructured":"Becker AS, Oehmcke-Hecht S, Dargel E, Kaps P, Freitag T, Kreikemeyer B, et al. Preclinical models of HNSCC and their role in drug discovery - an emphasis on the cancer microenvironment and microbiota. Expert Opin Drug Discov. 2025;20(1):81\u2013101.","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"4883_CR24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/hed.26566","volume":"43","author":"EM Anderson","year":"2021","unstructured":"Anderson EM, Luu M, Balzer BL, Scher KS, Mita AC, Lu DJ, et al. Variations in the association of grade with survival across the head and neck cancer landscape. Head Neck. 2021;43(4):1105\u201315.","journal-title":"Head Neck"},{"issue":"3","key":"4883_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/hed.27583","volume":"46","author":"E Zanoletti","year":"2024","unstructured":"Zanoletti E, Daloiso A, Nicol\u00e8 L, Cazzador D, Mondello T, Franz L, et al. Tumor budding to investigate local invasion, metastasis, and prognosis of head and neck carcinoma: A systematic review. Head Neck. 2024;46(3):651\u201371.","journal-title":"Head Neck"},{"issue":"2","key":"4883_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41571-020-0422-y","volume":"18","author":"A Lugli","year":"2021","unstructured":"Lugli A, Zlobec I, Berger MD, Kirsch R, Nagtegaal ID. Tumour budding in solid cancers. Nat Rev Clin Oncol. 2021;18(2):101\u201315.","journal-title":"Nat Rev Clin Oncol"},{"key":"4883_CR27","doi-asserted-by":"publisher","first-page":"104202","DOI":"10.1016\/j.critrevonc.2023.104202","volume":"193","author":"FFVE Silva","year":"2024","unstructured":"Silva FFVE, Caponio VCA, P\u00e9rez-Say\u00e1ns M, Pad\u00edn-Iruegas ME, Mascitti M, Chamorro-Petronacci CM, et al. Tumor budding is a prognostic factor in head and neck squamous cell carcinoma: A comprehensive meta-analysis and trial sequential analysis. Crit Rev Oncol Hematol. 2024;193:104202.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"4883_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/hed.25462","volume":"41","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Liu H, Xie N, Liu X, Huang H, Wang C, et al. Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis. Head Neck. 2019;41(2):542\u201350.","journal-title":"Head Neck"},{"key":"4883_CR29","doi-asserted-by":"publisher","first-page":"1376498","DOI":"10.3389\/fonc.2024.1376498","volume":"14","author":"T Wang","year":"2024","unstructured":"Wang T, Xue L, Li Z, Hong Z, Hu N, Li Y, et al. A novel nomogram model based on Ki-67 characteristic expression to predict prognosis in head and neck squamous cell carcinoma. Front Oncol. 2024;14:1376498.","journal-title":"Front Oncol"},{"issue":"1","key":"4883_CR30","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1038\/s41598-023-30939-8","volume":"13","author":"Q Huang","year":"2023","unstructured":"Huang Q, Huang Y, Chen C, Zhang Y, Zhou J, Xie C, et al. Prognostic impact of lymphovascular and perineural invasion in squamous cell carcinoma of the tongue. Sci Rep. 2023;13(1):3828.","journal-title":"Sci Rep"},{"issue":"7","key":"4883_CR31","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, et al. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell. 2017;171(7):1611\u2013e2424.","journal-title":"Cell"},{"key":"4883_CR32","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez R, Ortiz-Sarabia G, Molina-Frechero N, Salas-Pacheco JM, Salas-Pacheco SM, Lavalle-Carrasco J et al. Epithelial-Mesenchymal Transition Associated with Head and Neck Squamous Cell Carcinomas: A Review. Cancers (Basel) [Internet]. 2021;13(12). Available from: https:\/\/doi.org\/10.3390\/cancers13123027","DOI":"10.3390\/cancers13123027"},{"key":"4883_CR33","doi-asserted-by":"publisher","unstructured":"Baumeister P, Zhou J, Canis M, Gires O. Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas. Cancers (Basel) [Internet]. 2021;13(21). Available from: https:\/\/doi.org\/10.3390\/cancers13215355","DOI":"10.3390\/cancers13215355"},{"issue":"9","key":"4883_CR34","doi-asserted-by":"publisher","first-page":"e702","DOI":"10.1002\/mco2.702","volume":"5","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang N, Wen Y, Wen J. Head and neck cancer: pathogenesis and targeted therapy. MedComm. 2024;5(9):e702.","journal-title":"MedComm"},{"issue":"1","key":"4883_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12943-024-02179-5","volume":"23","author":"J Wei","year":"2024","unstructured":"Wei J, Li W, Zhang P, Guo F, Liu M. Current trends in sensitizing immune checkpoint inhibitors for cancer treatment. Mol Cancer. 2024;23(1):279.","journal-title":"Mol Cancer"},{"issue":"1","key":"4883_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10555-025-10246-6","volume":"44","author":"A Ezdoglian","year":"2025","unstructured":"Ezdoglian A, Tsang-A-Sjoe M, Khodadust F, Burchell G, Jansen G, de Gruijl T, et al. Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis. Cancer Metastasis Rev. 2025;44(1):35.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"4883_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41368-021-00131-7","volume":"13","author":"A Elmusrati","year":"2021","unstructured":"Elmusrati A, Wang J, Wang CY. Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma. Int J Oral Sci. 2021;13(1):24.","journal-title":"Int J Oral Sci"},{"key":"4883_CR38","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.2147\/JIR.S428358","volume":"16","author":"K Li","year":"2023","unstructured":"Li K, Zeng X, Liu P, Zeng X, Lv J, Qiu S, et al. The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma. J Inflamm Res. 2023;16:4301\u201315.","journal-title":"J Inflamm Res"},{"issue":"6","key":"4883_CR39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41416-019-0672-6","volume":"122","author":"IR Powley","year":"2020","unstructured":"Powley IR, Patel M, Miles G, Pringle H, Howells L, Thomas A, et al. Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery. Br J Cancer. 2020;122(6):735\u201344.","journal-title":"Br J Cancer"},{"key":"4883_CR40","doi-asserted-by":"publisher","unstructured":"Mehra S, Yom SS, Burtness B. Re-defining Standards of Care in Resectable Head and Neck Squamous Cell Carcinoma - Lessons from KEYNOTE-689 and NIVOPOSTOP. Oncologist [Internet]. 2025; Available from: https:\/\/doi.org\/10.1093\/oncolo\/oyaf404","DOI":"10.1093\/oncolo\/oyaf404"},{"issue":"1","key":"4883_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12859-025-06143-y","volume":"26","author":"K Liou","year":"2025","unstructured":"Liou K, Wang JP. Integrating genetic and gene expression data in network-based stratification analysis of cancers. BMC Bioinformatics. 2025;26(1):126.","journal-title":"BMC Bioinformatics"},{"key":"4883_CR42","doi-asserted-by":"publisher","unstructured":"Griso AB, Acero-Riaguas L, Castelo B, Cebri\u00e1n-Carretero JL, Sastre-Perona A. Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas. Cells [Internet]. 2022;11(3). Available from: https:\/\/doi.org\/10.3390\/cells11030561","DOI":"10.3390\/cells11030561"},{"issue":"1","key":"4883_CR43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.20517\/cdr.2022.107","volume":"6","author":"JM Siqueira","year":"2023","unstructured":"Siqueira JM, Heguedusch D, Rodini CO, Nunes FD, Rodrigues MFSD. Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma. Cancer Drug Resist. 2023;6(1):116\u201337.","journal-title":"Cancer Drug Resist"},{"key":"4883_CR44","doi-asserted-by":"publisher","first-page":"640392","DOI":"10.3389\/fonc.2021.640392","volume":"11","author":"Y Kanno","year":"2021","unstructured":"Kanno Y, Chen CY, Lee HL, Chiou JF, Chen YJ. Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers. Front Oncol. 2021;11:640392.","journal-title":"Front Oncol"},{"issue":"4","key":"4883_CR45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S1470-2045(20)30755-5","volume":"22","author":"J Guigay","year":"2021","unstructured":"Guigay J, Aup\u00e9rin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, et al. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol. 2021;22(4):463\u201375.","journal-title":"Lancet Oncol"},{"issue":"2","key":"4883_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","volume":"21","author":"BL LeSavage","year":"2022","unstructured":"LeSavage BL, Suhar RA, Broguiere N, Lutolf MP, Heilshorn SC. Next-generation cancer organoids. Nat Mater. 2022;21(2):143\u201359.","journal-title":"Nat Mater"},{"issue":"26","key":"4883_CR47","doi-asserted-by":"publisher","first-page":"e2300903","DOI":"10.1002\/adhm.202300903","volume":"12","author":"N Landon-Brace","year":"2023","unstructured":"Landon-Brace N, Li NT, McGuigan AP. Exploring New Dimensions of Tumor Heterogeneity: The Application of Single Cell Analysis to Organoid-Based 3D In Vitro Models. Adv Healthc Mater. 2023;12(26):e2300903.","journal-title":"Adv Healthc Mater"},{"key":"4883_CR48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-bioeng-110220-123503","volume":"24","author":"MC Skala","year":"2022","unstructured":"Skala MC, Deming DA, Kratz JD. Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids. Annu Rev Biomed Eng. 2022;24:157\u201377.","journal-title":"Annu Rev Biomed Eng"},{"issue":"1","key":"4883_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40164-022-00277-y","volume":"11","author":"Q Jia","year":"2022","unstructured":"Jia Q, Wang A, Yuan Y, Zhu B, Long H. Heterogeneity of the tumor immune microenvironment and its clinical relevance. Exp Hematol Oncol. 2022;11(1):24.","journal-title":"Exp Hematol Oncol"},{"key":"4883_CR50","doi-asserted-by":"publisher","unstructured":"Museedi OS, Abdullah BH, Al-Rawi NH. Investigating GSK-3\u03b2 as a Potential Prognostic Marker for Metastasis in Head and Neck Squamous Cell Carcinoma: A Preliminary Study on the Crossroads of GABAergic and Wnt Signaling. Eur J Dent [Internet]. 2026; Available from: https:\/\/doi.org\/10.1055\/s-0045-1814075","DOI":"10.1055\/s-0045-1814075"},{"issue":"1","key":"4883_CR51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/med.21806","volume":"42","author":"H Zaryouh","year":"2022","unstructured":"Zaryouh H, De Pauw I, Baysal H, Peeters M, Vermorken JB, Lardon F, et al. Recent insights in the PI3K\/Akt pathway as a promising therapeutic target in combination with EGFR-targeting agents to treat head and neck squamous cell carcinoma. Med Res Rev. 2022;42(1):112\u201355.","journal-title":"Med Res Rev"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04883-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04883-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04883-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:43:04Z","timestamp":1781649784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04883-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4883"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04883-z","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Ethics Committee of the Technical University of Munich (15\/21 S) and written informed consent was obtained from all patients. The analyses were conducted in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}